Insulin aspart significantly reduced post-prandial hyperglycemia and preserved flow-mediated vasodilation compared to regular insulin in patients with Type 2 diabetes (39.4 vs 34.1; P<0.01).
Does insulin aspart improve post-prandial endothelial dysfunction compared to regular insulin in patients with Type 2 diabetes?
Insulin aspart improves post-prandial endothelial function compared to regular insulin in patients with Type 2 diabetes, likely by better controlling post-prandial hyperglycemia.
Absolute Event Rate: 39.4% vs 34.1%
p-value: p=<0.01
OBJECTIVE: Recently, much attention has been focused on the possibility that the post-prandial state may be a cardiovascular risk factor in diabetes. The aim of the present study was to evaluate whether the post-prandial state is associated with endothelial dysfunction in patients with diabetes and to explore the effect on this aspect of managing post-prandial hyperglycaemia by insulin aspart. RESEARCH DESIGN AND METHODS: Twenty-three patients with Type 2 diabetes and 10 normal controls were recruited. In the diabetic patients two different tests were performed in each subject: a standard meal preceded by subcutaneous injection of soluble insulin (0.15 U/kg body weight) or of short-acting insulin aspart (0.15 U/kg body weight). These tests were designed to achieve different levels of post-prandial hyperglycaemia. Controls received a single standard meal test. Immediately before, and 1, 2, 4 and 6 h after each meal, blood glucose, triglycerides, free fatty acids and flow-mediated vasodilation were measured. RESULTS: Compared with regular insulin, insulin aspart significantly reduced the area under the curve for post-prandial hyperglycaemia (58.3 +/- 17.6 vs. 68.1 +/- 17.7; P<0.04), and preserved flow-mediated vasodilation, which was decreased in the post-prandial state (39.4 +/- 2.9 vs. 34.1 +/- 2.2; P<0.01). Triglyceride and free fatty acid levels were not differentially affected by the treatment. In normal controls the meal did not affect flow-mediated vasodilation. CONCLUSION: This study shows that the post-prandial state is accompanied by endothelial dysfunction in Type 2 diabetic patients and that insulin aspart improved endothelial function.
Ceriello et al. (Fri,) conducted a other in Type 2 diabetes (n=33). Insulin aspart vs. Soluble insulin (regular insulin) was evaluated on Flow-mediated vasodilation (p=<0.01). Insulin aspart significantly reduced post-prandial hyperglycemia and preserved flow-mediated vasodilation compared to regular insulin in patients with Type 2 diabetes (39.4 vs 34.1; P<0.01).